China to accept overseas trial data in bid to speed up drug approvals

SHANGHAI (Reuters) – China said it plans to accept data from overseas clinical trials to speed up approvals of drugs, a potential boon for international drugmakers as well as patients who often face lengthy delays for new medicines to reach the market.

Source: Reuters Health News